Max Healthcare Institute Ltd.
Snapshot View

View in App

Prices View details >>

462.95 -3.70 ▼-0.8%

24 March 2023, 04:01:00 PM
Volume: 21,162

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.maxhealthcare.in
Market Cap 44,783.82 Cr.
Enterprise Value(EV) 44,593.97 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 10.06 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 46.04 Trailing Twelve Months Ending 2022-12
Industry PE 45.84 Trailing Twelve Months Ending 2022-12
Book Value / Share 73.27 Trailing Twelve Months Ending 2022-12
Price to Book Value 6.32 Calculated using Price: 462.95
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 97.09 Cr. 970,922,825 Shares
FaceValue 10
Company Profile
The company offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda. It provides services in the areas of cardiology, orthopedics and joint replacement, cancer, neurosciences, pediatrics, obstetrics and gynecology, aesthetics and reconstructive plastic surgery, internal medicine, eye and dental care, endocrinology, diabetes, obesity, ENT, metal health and behavioral sciences, physiotherapy and rehabilitation, and nuclear medicine, as well as minimal access, metabolic, and bariatric surgery.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.79%
1 Week
+0.60%
1 Month
+7.21%
3 Month
+7.09%
6 Month
+8.47%
1 Year
+39.23%
2 Year
+128.05%
5 Year
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -13.37 -5.64 -2.29 1.35 -2.44 -0.02 0.73 -2.80 10.19
Return on Capital Employed (%) -0.20 2.11 3.05 5.20 3.46 5.33 3.57 2.22 12.38
Return on Assets (%) -5.05 -2.71 -1.01 0.51 -0.89 -0.01 0.35 -1.83 6.82

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 549 831 1,145 1,192 1,167 963 2,553 5,639 6,282 6,918
Non Curr. Liab. 411 339 1,495 1,647 1,792 1,251 411 2,128 2,149 1,775
Curr. Liab. 320 282 422 380 478 1,140 1,010 777 757 811
Minority Int. -17 -73 -133
Equity & Liab. 1,280 1,453 3,045 3,146 3,304 3,355 3,974 8,543 9,189 9,504
Non Curr. Assets 1,047 1,069 2,755 2,797 2,872 2,907 1,058 7,419 8,189 8,171
Curr. Assets 233 383 290 349 432 447 2,915 1,124 1,000 1,332
Misc. Exp. not W/O
Total Assets 1,280 1,453 3,045 3,146 3,304 3,355 3,974 8,543 9,189 9,504

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 944 1,134 1,434 1,637 1,729 1,691 1,059 2,508 3,931 4,283
Other Income 23 27 36 43 55 67 53 135 137 127
Total Income 968 1,161 1,471 1,680 1,784 1,758 1,112 2,643 4,068 4,411
Total Expenditure -915 -1,058 -1,331 -1,468 -1,616 -1,546 -970 -2,124 -2,998 -3,176
PBIDT 53 102 140 212 167 212 142 519 1,070 1,234
Interest -62 -61 -68 -100 -99 -101 -83 -179 -101 -86
Depreciation -55 -78 -91 -108 -94 -103 -46 -174 -221 -230
Taxation 0 -4 11 -2 -9 0 -46 -134 59
Exceptional Items -234 -9
PAT -65 -37 -23 16 -29 0 13 -115 605 976
Minority Interest -3 -3
Share Associate 46 -23
Other Related Items
Consolidated Net Profit -65 -37 -23 16 -21 -3 59 -138 605 976
Adjusted EPS -2 -1 0 0 -1 0 1 -1 6 10

Cash Flow View Details >>

Particulars 6 years 2016-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 723 82 89 77 118 748
Cash Fr. Inv. -1,340 -100 -17 -2,641 -73 -772
Cash Fr. Finan. 603 12 -74 2,353 191 -294
Net Change -14 -6 -2 -210 236 -317
Cash & Cash Eqvt 11 9 8 111 627 309

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 75.25 70.46 70.46 60.91 60.68 50.64 50.64 23.80 23.78
Public 24.75 29.54 29.54 39.09 39.32 49.36 49.36 76.20 76.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 42.69 51.15 51.15 0.00 0.00

Announcements View Details >>

Thu, 16 Mar 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares pursuant to exercise of vested stock options under Max Healthcare Institute Limited - Employee Stock Option Plan 2020
Sun, 26 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meet
Tue, 21 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Conferences

Technical Scans View Details >>

Fri, 24 Mar 2023
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,497.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,309.73 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,557.09 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,379.40 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Max Healthcare Institute Ltd.

What is Max Healthcare Inst share price?
Can I buy Max Healthcare Inst shares now?
What is the Market Cap of Max Healthcare Inst?
What are the key metrics to analyse Max Healthcare Inst?
What is the 52 Week High and Low of Max Healthcare Inst?
What is the trend of Max Healthcare Inst share price?